BioSpace News Archive

Monoclonal Antibodies Market Size to Hit US$ 150.4 Bn by 2030

The Monoclonal Antibodies market was estimated at US$ 95.4 billion in 2020 and is expected to hit around US$ 150.4 billion by 2030, growing at a CAGR of 15.7% from 2021 to 2030.

May 4, 2022
·
3 min read
Ophthalmic Ultrasound Devices Market to Hit US$ 887.7 Million by 2030

The global Ophthalmic Ultrasound Devices market size is predicted to hit around US$ 887.7 million by 2030 from valued at US$ 487.50 million in 2020 and growing at a CAGR of 9.36% during forecast period 2021 to 2030.

May 4, 2022
·
4 min read
Orthopedic Soft Tissue Repair Market Size to Hit US$ 19.39 Bn by 2030

The global Orthopedic Soft Tissue Repair market size is expected to be worth around US$ 19.39 billion by 2030 from valued at US$ 15.0 billion in 2020 with a CAGR of 6.5% from 2021 to 2030.

May 4, 2022
·
4 min read
BioForest

Umoja Biopharma Presents Data on its Synthetic Cytokine Receptor Platform at the International Society for Cell and Gene Therapy Annual Meeting 2022

Umoja Biopharma, Inc. announced that it will have an oral presentation at the International Society for Cell and Gene Therapy Annual Meeting 2022, to be held May 4-7, 2022 in San Francisco, California.

May 4, 2022
·
4 min read
Contraceptives Market Size to Hit USD 44.7 BN by 2030

The global contraceptives market was valued at USD 21.8 billion in 2021 and is projected to hit USD 44.7 billion by 2030 poised to grow at a CAGR of 10% from 2022 to 2030.

May 4, 2022
·
5 min read
Stem Cells Market Size to Hit USD 29.68 Bn by 2030

The global stem cells market was estimated at USD 12.53 billion in 2021 and it is projected to hit around USD 29.68 billion by 2030 poised to grow at a CAGR of 12.4% from 2022 to 2030.

May 4, 2022
·
6 min read
Business

AVACEN Medical® Welcomes Anthony Shimkin as New Chief Executive Officer

An industry veteran, Shimkin brings more than 25 years of medical and technology commercialization experience to AVACEN.

May 4, 2022
·
2 min read
Business

Julianne Averill and Kristen Richardson Join Anji Pharma to Ready Company for Next Stage of Growth

Anji Pharma, an emerging global medicines company, announced an expanded leadership team with the appointments of Julianne Averill as Chief Financial Officer and Kristen Richardson as Chief People and Performance Officer.

May 4, 2022
·
4 min read
Business

Moleculin Engages Wolfram C. M. Dempke, MD, PhD, MBA as its European Chief Medical Officer

Moleculin Biotech, Inc. today announced that the Company has engaged Wolfram C. M. Dempke, MD, PhD, MBA, MRCP as its EU Chief Medical Officer and part-time contractor for its European clinical trials.

May 4, 2022
·
6 min read
Drug Development

Imfinzi Plus Chemotherapy Granted Priority Review in the US for Patients With Locally Advanced or Metastatic Biliary Tract Cancer Based on TOPAZ-1 Phase III Trial

AstraZeneca’s supplemental Biologics License Application (sBLA) for Imfinzi (durvalumab), in combination with standard-of-care chemotherapy, has been accepted and granted Priority Review in the US for patients with locally advanced or metastatic biliary tract cancer (BTC).

May 4, 2022
·
18 min read